Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short vs Long-term ON-Q Nerve Block for TKA Pain
NCT03245359Completed
- Sponsor
- AdventHealth
- Start
- Sep 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in pain (2 arms), sponsored by AdventHealth. Primary endpoints: Change from Baseline Day of Surgery Pain Scores at 6 Weeks, Opioid and Analgesic Use at 7 days and 2 more. Started Sep 2017; status: completed.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03245359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03245359.